CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-08 | Lian Brian President & CEO | Sale 10b5-1 | −40,000 | $28.90 | $1.2M | 2,184,882 |
| 2024-02-08 | Lian Brian President & CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,148 | 0 | ||
| 2024-02-08 | Lian Brian President & CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −34,931 | 0 | ||
| 2024-02-08 | Lian Brian President & CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −140,000 | 0 | ||
| 2024-02-08 | Rouan Sarah Kathryn Director | Option exercise 10b5-1 | +25,000 | $8.32 | $208K | 25,000 |
| 2024-02-08 | Rouan Sarah Kathryn Director | Sale 10b5-1 | −25,000 | $28.05 | $701K | 0 |
| 2024-02-08 | Rouan Sarah Kathryn Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 0 | ||
| 2024-01-31 | Lian Brian President & CEO | Option exercise 10b5-1 | +85,000 | $1.23 | $105K | 2,349,882 |
| 2024-01-31 | Lian Brian President & CEO | Sale 10b5-1 | −40,000 | $24.45 | $978K | 2,309,882 |
| 2024-01-31 | Lian Brian President & CEO | Sale 10b5-1 | −45,000 | $24.95 | $1.1M | 2,264,882 |
| 2024-01-31 | Lian Brian President & CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −85,000 | 14,148 | ||
| 2024-01-30 | Lian Brian President & CEO | Option exercise 10b5-1 | +35,000 | $1.23 | $43K | 2,299,882 |
| 2024-01-30 | Lian Brian President & CEO | Sale 10b5-1 | −35,000 | $23.95 | $838K | 2,264,882 |
| 2024-01-30 | Lian Brian President & CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −35,000 | 99,148 | ||
| 2024-01-19 | Rouan Sarah Kathryn Director | Option exercise 10b5-1 | +30,000 | $8.32 | $250K | 30,000 |
| 2024-01-19 | Rouan Sarah Kathryn Director | Sale 10b5-1 | −30,000 | $23.05 | $692K | 0 |
| 2024-01-19 | Rouan Sarah Kathryn Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 25,000 | ||
| 2024-01-04 | Lian Brian President & CEO | Shares withheld for taxes | −39,552 | $18.58 | $735K | 2,264,882 |
| 2024-01-04 | Mancini Marianna Chief Operating Officer | Shares withheld for taxes | −14,199 | $18.58 | $264K | 333,799 |
| 2024-01-04 | ZANTE GREG Chief Financial Officer | Shares withheld for taxes | −13,872 | $18.58 | $258K | 195,730 |
Page 11 of 27 · 528 trades